Phani Kanumuri – HSBC

HSBC

An HSBC analyst with 20 tracked ratings across 12 distinct tickers has a 2.6-star track record and a 44.4% success rate on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

1 months ago

2026-04-27 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 2
Hold: 3
Bearish: 0

Aggregated

44% success rate

Bullish: 0
Hold: 1
Bearish: 0

Aggregated

Not available

Bullish: 6
Hold: 2
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
DLR	2026-04-27	hold	$210.00	Aggregated
EQIX	2026-04-27	buy	$1250.00	Aggregated
ACN	2026-03-20	hold	$220.00	Aggregated
TIGO	2026-03-06	buy	$89.00	Aggregated
DLR	2026-01-15	buy	$193.00	Aggregated
TIMB	2025-11-05	buy	$27.00	Aggregated
TIMBTIM SA - ADR	2025-11-05	unknown	$27.00	Aggregated
ACNACCENTURE PLC - ORDINARY SHARES - CLASS A	2025-07-28	unknown	$240.00	Aggregated
TIGO	2024-07-02	hold	-	Aggregated
DAVAENDAVA PLC - ADR	2024-05-01	unknown	$45.00	Aggregated
TIGO	2024-04-11	buy	$24.00	Aggregated
TIGOMILLICOM INTERNATIONAL CELLULAR S.A.	2024-04-11	unknown	$24.00	Aggregated
EPAMEPAM SYSTEMS INC	2024-04-03	unknown	$345.00	Aggregated
GLOBGLOBANT S.A.	2024-04-03	unknown	$270.00	Aggregated
EQIXEQUINIX INC	2024-03-20	hold	$900.00	Aggregated
TIGO	2024-02-28	buy	$22.50	Aggregated

Tickers covered(12)

Ticker	Ratings	Last rating	Sources
DLR	4	2026-04-27	Aggregated
EQIX	2	2026-04-27	Aggregated
ACN	1	2026-03-20	Aggregated
TIGO	4	2026-03-06	Aggregated
TIMB	2	2025-11-05	Aggregated
TIMBTIM SA - ADR	1	2025-11-05	Aggregated
ACNACCENTURE PLC - ORDINARY SHARES - CLASS A	1	2025-07-28	Aggregated
DAVAENDAVA PLC - ADR	1	2024-05-01	Aggregated
TIGOMILLICOM INTERNATIONAL CELLULAR S.A.	1	2024-04-11	Aggregated
EPAMEPAM SYSTEMS INC	1	2024-04-03	Aggregated
GLOBGLOBANT S.A.	1	2024-04-03	Aggregated
EQIXEQUINIX INC	1	2024-03-20	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.